Andrew T. Wilkins, Ph.D.

Andrew Wilkins is a patent agent with a focus on biotechnology. He has experience in drafting and prosecuting U.S. and foreign patent applications, performing freedom to operate analyses, and drafting non-infringement and invalidity opinions for clients in the biotechnology industry. Areas of Dr. Wilkins’ expertise include therapeutic antibodies and antibody-like molecules, RNAi, gene therapy vectors, vaccines, protein purification methods, screening assays, and biocompatible drug delivery vehicles. He is currently pursuing his juris doctorate at Suffolk University Law School, with an expected graduation in 2012.

Dr. Wilkins’ prior experience includes serving as an undergraduate research student with Celltech, a graduate research student with GlaxoSmithKline and a postdoctoral research associate with MRC Laboratory of Molecular Biology. Dr. Wilkins has also served as a postdoctoral research fellow and Instructor in Medicine at Harvard Medical School/Beth Israel Deaconess Medical Center in Boston.

Honors

• Suffolk Law School First Year Best Oral Advocate Award, 2009
• Suffolk Law School First Year Honorable Mention Brief Award, 2009
• Suffolk Law School Dean’s List, 2009 and 2010
• Charles A. King Trust Postdoctoral Fellowship, 2005
• Wellcome Trust International Prize Postdoctoral Research Fellowship, 2001
• Human Frontiers Science Project Postdoctoral Research Fellowship (declined), 2001

  ---

Publications

• Author/co-author of 12 articles and reviews in internationally recognized, peer-reviewed journals including: Genes and Development, Current Biology, Biochemical Journal, Genome Biology, Cell Motility and the Cytoskeleton, Trends in Genetics, and Methods in Enzymology.